TY - JOUR
T1 - Incidence and clinical significance of poststent optical coherence tomography findings
T2 - One-year follow-up study from a multicenter registry
AU - Soeda, Tsunenari
AU - Uemura, Shiro
AU - Park, Seung Jung
AU - Jang, Yangsoo
AU - Lee, Stephen
AU - Cho, Jin Man
AU - Kim, Soo Joong
AU - Vergallo, Rocco
AU - Minami, Yoshiyasu
AU - Ong, Daniel S.
AU - Gao, Lei
AU - Lee, Hang
AU - Zhang, Shaosong
AU - Yu, Bo
AU - Saito, Yoshihiko
AU - Jang, Ik Kyung
N1 - Publisher Copyright:
© 2015 American Heart Association, Inc.
PY - 2015/9/15
Y1 - 2015/9/15
N2 - Background: Optical coherence tomography (OCT) was recently introduced to optimize percutaneous coronary intervention. However, the exact incidence and significance of poststent OCT findings are unknown. Methods and Results: A total of 900 lesions treated with 1001 stents in 786 patients who had postprocedure OCT imaging were analyzed to evaluate the incidence of poststent OCT findings and to identify the OCT predictors for device-oriented clinical end points, including cardiac death, target vessel-related myocardial infarction, target lesion revascularization, and stent thrombosis. Patients were followed up to 1 year. Stent edge dissection was detected in 28.7% of lesions, and incomplete stent apposition was detected in 39.1% of lesions. The incidences of smooth protrusion, disrupted fibrous tissue protrusion, and irregular protrusion were 92.9%, 61.0%, and 53.8%, respectively. Small minimal stent area, defined as a lesion with minimal stent area <5.0 mm2 in a drug-eluting stent or <5.6 mm 2 in a bare metal stent, was observed in 40.4% of lesions. One-year device-oriented clinical end points occurred in 33 patients (4.5%). Following adjustment, irregular protrusion and small minimal stent area were independent OCT predictors of 1-year device-oriented clinical end points (P=0.003 and P=0.012, respectively). Conclusions: Abnormal poststent OCT findings were frequent. Irregular protrusion and small minimal stent area were independent predictors of 1-year device-oriented clinical end points, which were primarily driven by target lesion revascularization.
AB - Background: Optical coherence tomography (OCT) was recently introduced to optimize percutaneous coronary intervention. However, the exact incidence and significance of poststent OCT findings are unknown. Methods and Results: A total of 900 lesions treated with 1001 stents in 786 patients who had postprocedure OCT imaging were analyzed to evaluate the incidence of poststent OCT findings and to identify the OCT predictors for device-oriented clinical end points, including cardiac death, target vessel-related myocardial infarction, target lesion revascularization, and stent thrombosis. Patients were followed up to 1 year. Stent edge dissection was detected in 28.7% of lesions, and incomplete stent apposition was detected in 39.1% of lesions. The incidences of smooth protrusion, disrupted fibrous tissue protrusion, and irregular protrusion were 92.9%, 61.0%, and 53.8%, respectively. Small minimal stent area, defined as a lesion with minimal stent area <5.0 mm2 in a drug-eluting stent or <5.6 mm 2 in a bare metal stent, was observed in 40.4% of lesions. One-year device-oriented clinical end points occurred in 33 patients (4.5%). Following adjustment, irregular protrusion and small minimal stent area were independent OCT predictors of 1-year device-oriented clinical end points (P=0.003 and P=0.012, respectively). Conclusions: Abnormal poststent OCT findings were frequent. Irregular protrusion and small minimal stent area were independent predictors of 1-year device-oriented clinical end points, which were primarily driven by target lesion revascularization.
UR - http://www.scopus.com/inward/record.url?scp=84941778953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941778953&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.114.014704
DO - 10.1161/CIRCULATIONAHA.114.014704
M3 - Article
C2 - 26162917
AN - SCOPUS:84941778953
SN - 0009-7322
VL - 132
SP - 1020
EP - 1029
JO - Circulation
JF - Circulation
IS - 11
ER -